Frederick J Raal (F Raal, Frederick Raal)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Topics

Low Density Lipoprotein

Top Venues

Journal of clinical medicine

Annals of medicine

PLOS global public health

European heart journal

This page only lists publications with an associated author ORCID identifier.

Publications

Alpo Vuorio, Bruce Budowle, Frederick J Raal, Petri T Kovanen
Statins for the prevention of cardiovascular events associated with avian influenza: the COVID-19 pandemic as a reference. Annals of medicine 56 (1) (2024)
Alana T Brennan, Emma M Kileel, M P Fox, J A George, Siyabonga Khoza, Sydney Rosen, Frederick J Raal, P Hibberd, K Chetty, K Mlisana, Jacob Bor, Nigel John Crowther
Assessing compliance with national guidelines in diabetes care: A study leveraging data from south Africa's National Health Laboratory Service (NHLS). PLOS global public health 4 (9) (2024)
Brett Stephen Mansfield, Farzahna Mohamed, Miriam Larouche, Frederick J Raal
The Hurdle of Access to Emerging Therapies and Potential Solutions in the Management of Dyslipidemias. Journal of clinical medicine 13 (14) (2024)
Alpo Vuorio, Bruce Budowle, Frederick J Raal, Petri T Kovanen
Statins for the prevention of cardiovascular events associated with avian influenza: the COVID-19 pandemic as a reference. Annals of medicine 56 (1) (2024)
Jing Gu, Rupal N Gupta, Henry Cheng, Yingxin Xu, Frederick J Raal
Current treatments for the management of homozygous familial hypercholesterolemia: a systematic review and commentary. European journal of preventive cardiology (2024)
Farzahna Mohamed, Frederick J Raal
Unraveling the Whipple Triad: Non-Islet Cell Tumor-Induced Hypoglycemia. JCEM case reports 2 (2) (2024)
Alana T Brennan, Emma M Kileel, M P Fox, J A George, Siyabonga Khoza, Sydney Rosen, Frederick J Raal, P Hibberd, K Chetty, K Mlisana, Jacob Bor, Nigel John Crowther
Assessing compliance with national guidelines in diabetes care: A study leveraging data from south Africa's National Health Laboratory Service (NHLS). PLOS global public health 4 (9) (2024)
Brett Stephen Mansfield, Farzahna Mohamed, Miriam Larouche, Frederick J Raal
The Hurdle of Access to Emerging Therapies and Potential Solutions in the Management of Dyslipidemias. Journal of clinical medicine 13 (14) (2024)
Brett Stephen Mansfield, Farzahna Mohamed, Miriam Larouche, Frederick J Raal
The Hurdle of Access to Emerging Therapies and Potential Solutions in the Management of Dyslipidemias. Journal of clinical medicine 13 (14) (2024)
Alpo Vuorio, Bruce Budowle, Frederick J Raal, Petri T Kovanen
Statins for the prevention of cardiovascular events associated with avian influenza: the COVID-19 pandemic as a reference. Annals of medicine 56 (1) (2024)
Alana T Brennan, Emma M Kileel, M P Fox, J A George, Siyabonga Khoza, Sydney Rosen, Frederick J Raal, P Hibberd, K Chetty, K Mlisana, Jacob Bor, Nigel John Crowther
Assessing compliance with national guidelines in diabetes care: A study leveraging data from south Africa's National Health Laboratory Service (NHLS). PLOS global public health 4 (9) (2024)
Farzahna Mohamed, Frederick J Raal
Unraveling the Whipple Triad: Non-Islet Cell Tumor-Induced Hypoglycemia. JCEM case reports 2 (2) (2024)
Farzahna Mohamed, Brett Stephen Mansfield, Frederick J Raal
Targeting PCSK9 and Beyond for the Management of Low-Density Lipoprotein Cholesterol. Journal of clinical medicine 12 (15) (2023)
Frederick J Raal, Nyda Fourie, Russell Scott, Dirk Blom, Matthys De Vries Basson, Meral Kayikcioglu, Kate Caldwell, David Kallend, Evan Stein, null null
Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial. European heart journal (2023)
Alpo Vuorio, Petri T Kovanen, Frederick J Raal
Coronary microcirculatory dysfunction in hypercholesterolemic patients with COVID-19: potential benefit from cholesterol-lowering treatment. Annals of medicine 55 (1) (2023)
Farzahna Mohamed, Frederick J Raal
Severe Hypophosphatemia: The Hidden Truth. Clinical chemistry 69 (5) (2023)
Marina Cuchel, Frederick J Raal, Robert A Hegele, Khalid Al-Rasadi, Marcello Arca, Maurizio Rocco Averna, Eric Bruckert, Tomas Freiberger, Daniel Gaudet, Mariko Harada-Shiba, Lisa C Hudgins, Meral Kayıkçıoğlu, Lluis Masana, Klaus G Parhofer, Jeanine E Roeters van Lennep, Raul Dias Dos Santos Filho, Erik S G Stroes, Gerald F Watts, Albert Wiegman, Jane K Stock, Lale S Tokgözoğlu, Alberico Luigi Catapano, Kausik K Ray
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. European heart journal (2023)
Farzahna Mohamed, Frederick J Raal
Severe Hypophosphatemia: The Hidden Truth. Clinical chemistry 69 (5) (2023)
Gerald F Watts, Samuel S Gidding, Robert A Hegele, Frederick J Raal, Amy C Sturm, Laney K Jones, Mitchell N Sarkies, Khalid Al-Rasadi, Dirk Jacobus Blom, Magdalena Daccord, Sarah D de Ferranti, Emanuela Folco, Peter Libby, Pedro Mata, Hapizah M Nawawi, Uma Ramaswami, Kausik K Ray, Claudia Stefanutti, Shizuya Yamashita, Jing Pang, Gilbert R Thompson, Raul Dias Dos Santos Filho
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia. Nature reviews. Cardiology (2023)
Frederick J Raal, Ronen Durst, Ran Bi, Zsolt Talloczy, Pierre Maheux, Anastasia Lesogor, John J P Kastelein, null null
Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial. Circulation (2023)
Reinhardt Hesse, Frederick J Raal, Dirk Jacobus Blom, Jaya A George
Familial Hypercholesterolemia Identification by Machine Learning Using Lipid Profile Data Performs as Well as Clinical Diagnostic Criteria. Circulation. Genomic and precision medicine 15 (5) (2022)
Kausik K Ray, David Kallend, Lawrence A Leiter, Frederick J Raal, Wolfgang Koenig, Mark J Jaros, Gregory G Schwartz, Ulf Landmesser, Lorena Garcia Conde, R Scott Wright, null null
Effect of inclisiran on lipids in primary prevention: the ORION-11 trial. European heart journal (2022)
Farzahna Mohamed, Brett Stephen Mansfield, Frederick J Raal
ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis. Current atherosclerosis reports (2022)
Alpo Vuorio, Petri T Kovanen, Frederick J Raal
LETTER TO THE EDITOR. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Farzahna Mohamed, Frederick J Raal
Hyperpigmentation from Addison's Disease. The New England journal of medicine 384 (18) (2021)
Gerald F Watts, Frederick J Raal, Gerald F Watts
Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3. Future cardiology (2021)
Yacob Pinchevsky, Neil Butkow, Frederick J Raal, Tobias F Chirwa, Alan Rothberg
Demographic and Clinical Factors Associated with Development of Type 2 Diabetes: A Review of the Literature. International journal of general medicine 13 (2020)